Many experts have raised the alarm that the COVID-19 pandemic was dominated by the gunshot1 and a greater agenda to impose totalitarian control globally.2 One gunshot has already turned into two doses and a third booster. A fourth booster is also being discussed, including by Moderna CEO Stéphane Bancel, who said the effectiveness of the third injection will likely decrease over the course of a few months, requiring another injection shortly after.3
“I’ll be surprised if in the coming weeks we get that data that holds up well over time — I wouldn’t expect it to stay great,” Bancel said in an interview with Goldman Sachs. on an Omicron-specific jab they hope to release in March 20225 — and this is just the beginning.
Eugyppius wrote on Substack, “Moderna, just one of many pharmaceutical companies eager to exploit our new vaccine mania, is expanding their manufacturing capacity to produce as many as 6 billion mRNA vaccine doses per year.”6 The information came straight from the horse’s mouth, at a virtual meeting on the first day of the Davos Agenda 2022 of the World Economic Forum (WEF), during a session entitled “COVID-19: What’s Next?”7
Along with Bancel, the meeting was attended by Dr. Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID), Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI), and Professor Annelies Wilder-Smith of the London School of Hygiene and Tropical Medicine, who together lay out their plans to ensure that “vaccine mania” continues indefinitely.
Combined shots planned to avoid ‘compliance issues’
During the discussion, Bancel states that Moderna is actively preparing “what should be the vaccine in the fall of 2022 and what should it contain.” The company “is working with public health experts like Fauci’s team to find out. Because we will soon have to decide what goes in the vaccine for the fall of 2022,” he said
Fauci’s NIAID is part of the US National Institutes of Health (NIH), which, some may be surprised to learn, actually owns half of the patent for Moderna’s COVID-19 injection. In fact, the NIH owns thousands of pharmaceutical patents, and the US Centers for Disease Control and Prevention spend $4.9 billion a year of their $12 billion budget buying and distributing vaccines.
“Tony Fauci was able to choose four of his senior employees, each of whom will receive individual patent shares,” said Robert F. Kennedy Jr. in an interview with James Corbett.9 “They will raise $150,000 a year for life if the Moderna vaccine is approved, which it has been
In addition to working closely with Fauci, Moderna plans to combine multiple injections, such as a COVID-19 shot, a flu shot, and a respiratory syncytial virus (RSV) shot, into one shot — coming in 2023 — to help prevent that “compliance problems.” He said:11
“The other piece we are working on is for 2023, how do we make it socially possible for people to want to be vaccinated?
And we’re going to do this by doing combinations, we’re working on the flu vaccine, we’re working on an RSV vaccine, and our goal is to be able to have a single annual booster so we don’t have compliance issues where people don’t have two to three injections. want to get only one dose per winter, where they get a booster for corona, and a booster for flu and RSV, to make sure people get their vaccine. ”
When asked how soon this would happen, he continued:12,13
“So the RSV program is now in phase 3, the flu program in phase 2 and soon in phase 3, I hope as soon as the second quarter of this year. So the best scenario would be the fall of 2023, at best I don’t think it would be [be available] in every country, but we think it is possible to be active in some countries next year.”
Vaccines for at least 20 pathogens in the works
SARS-Cov-2 isn’t the only virus that Moderna and other drug companies, along with health officials, are looking to attack with more shots. Do you remember the Zika virus, which Kennedy described as a new pandemic manufactured for the purpose of selling drugs and promoting totalitarian control?14 A vaccine is on the way.
What about the Nipah virus? Nipah virus, a zoonotic pathogen for which there are no treatments, is the inspiration for the film ‘Contagion’.15 The virus can only be experimented with in BSL-4 laboratories. As an aside, the National Bio and Agro-Defense Facility in Kansas will be the first biocontainment facility16 in the US to conduct Nipah (and Ebola) research on livestock.
In 2019, Nipah Malaysia was also among the deadly virus strains shipped17 from Canada’s National Microbiology Lab to the Wuhan Institute of Virology. If you’ve never heard of Nipah, you probably will soon — another vaccine is in the works. Bancel said:18,19
“We are working with the team of Dr. Fauci, we work with Richard [Hatchett]to work on many more pathogens… The whole scientific community has known for years that there are at least like 20 like pathogens that we need vaccines for, you know we have a zika vaccine in phase 2… we working on a Nipah vaccine, which are viruses that not everyone has heard of.
Because we need the data. What dose, what construct is required from a genetic point of view… so that if a new pathogen comes out of that family, we can move to a phase 3 very quickly.”
More mRNA recordings are coming
Many other vaccines are also in development, including a Phase 3 trial looking at combining Pfizer’s COVID-19 injection with their Prevnar 20™ (pneumococcal 20-valent conjugate vaccine) for adults aged 65 and over .20
In a related press release, Kathrin U. Jansen, Ph.D., senior vice president and head of vaccine research and development at Pfizer, spoke about the importance of “raising awareness about the importance of vaccinations for adults,” echoing Bancel in their desire to create combination shots so that adults can receive multiple vaccines in one doctor or pharmacy visit.
“As the COVID-19 vaccines and booster doses continue to be administered, we believe healthcare providers have the opportunity to talk to their adult patients about other recommended vaccines in line with CDC guidelines,” she said.21
An agreement between Pfizer and BioNTech to develop the first mRNA shingles vaccine was also reached in January 2022.22 According to a Pfizer press release, “While there are currently approved vaccines for shingles, there is an opportunity to develop an improved vaccine that may exhibits high efficacy and better tolerability, and is more efficient to produce globally, using mRNA technology.”23
A phase 1 study by Moderna for its mRNA Epstein-Barr virus shot is also underway. The first dose of the experimental shot was given to a subject on January 5, 2022. In a press release, Moderna describes their intention to also roll out additional mRNA vaccines against a number of additional viruses:24
“The initiation of this Phase 1 study is an important milestone as we continue to develop mRNA vaccines against latent viruses, which remain in the body for life after infection and can lead to chronic medical conditions. Moderna is committed to developing of a portfolio of first-in-class vaccines against latent viruses for which there are currently no approved vaccines, including vaccines against CMV [cytomegalovirus]EBV and HIV.
Our research team is working to bring even more vaccines against latent viruses to the clinic. We believe these vaccines can have a profound impact on the quality of health of hundreds of millions of people around the world.”
Other mRNA shots also in development include:
An mRNA cancer vaccine for non-small cell lung cancer (NSCLC)25 mRNA flu shots, which are under development by several companies, including Pfizer, Moderna, Sanofi and Translate Bio26 An mRNA HIV vaccine, one of which is being studied by Moderna in collaboration with the NIH27 Several complementary mRNA cancer vaccines, including one targeting advanced melanoma — developed by BioNTech and Regeneron Pharmaceuticals28 — and several under development by Moderna, targeting melanoma, NSCLC, colorectal cancer and pancreatic cancer29
Boost production for billions of doses
Just in case there was any doubt that those in power intend to use injections as an increasingly integral part of your healthcare routine and daily life, Bancel described plans to produce billions of doses of injections within months. He said during the WEF session: 30.31
“The other part is production. If you look in 2020, we were able to ship 20 million doses to the US government when the vaccine was approved. That’s not much.
But this year, we’ve got a capacity of 2 to 3 billion doses in a six-month time frame, and that’s what I think we’re going to need to get approval for a vaccine, if all the work is done before… you could have 1.5 billion doses available in six months, and that’s just from Moderna. And you have other platforms, it could be a much larger number…”
With censorship so ubiquitous and Big Tech colluding with dictators and drug companies to bury the damage caused by these experimental vaccines—including death—it’s now more important than ever to get your voice heard in support of medical freedom and opposition to the health of government officials who intimidate, threaten and force citizens to violate their conscientious beliefs.
The ethical principle of informed consent for taking medical risks, including the legal right to make voluntary decisions about receiving experimental injections, must be protected. For now, however, as Eugyppius explained:
“The vaccinators are a great sword of Damocles over our heads. As I type this, they are scouring the Earth for the new pathogens their products require, and they, along with their bureaucratic and academic allies, will do their very best to conjure up new pandemics and vaccination campaigns whenever possible—perhaps any flu. season.”
This post Vaccinations don’t stop vaccinating
was original published at “http://articles.mercola.com/sites/articles/archive/2022/02/04/vaccine-mania.aspx”